Clinical Trial Update: Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity [NA]

View source ↗

Summary

A trial sponsored by Helmholtz Zentrum München is evaluating supplementation with Bifidobacterium infantis to mitigate Type 1 diabetes autoimmunity; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Bifidobacterium infantis (Bifidobacterium infantis)

Snippet

Sponsor: Helmholtz Zentrum München | Conditions: Diabetes Mellitus, Type 1 | NA | Status: ACTIVE_NOT_RECRUITING